Bowen Acquisition Corp Faces Imminent Nasdaq Delisting; Deadline to Appeal Set for July 22, 2025

Reuters
Jul 19
<a href="https://laohu8.com/S/BOWN">Bowen Acquisition Corp</a> Faces Imminent Nasdaq Delisting; Deadline to Appeal Set for July 22, 2025

Bowen Acquisition Corp (NASDAQ: BOWN), a special purpose acquisition company, has received a notification from Nasdaq indicating that its securities are subject to delisting from the Nasdaq Global Market. The delisting is due to Bowen's failure to meet specific listing requirements, including minimum market value and shareholding criteria, for a sustained period. The company has been working to complete a business combination with Shenzhen Qianzhi BioTechnology Co. Ltd., which it believes will address these issues. Bowen has until July 22, 2025, to appeal Nasdaq's decision. If no appeal is made by this date, trading of Bowen's securities will be suspended on July 24, 2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bowen Acquisition Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-020251), on July 18, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10